熱門資訊> 正文
T2 BiomSystems向欧洲分销商出售四台T2 Dx仪器
2024-12-18 22:20
- T2 Biosystems (NASDAQ:TTOO) said it will sell four T2Dx Instruments to its European distributor.
- The sale shows commercial expansion to help enable more utilization of the T2Bacteria Panel, the T2Candida Panel, and the T2Resistance Panel.
- “Our international distributors continue to expand the global footprint of the T2Dx Instruments and make direct-from-blood diagnostic tests available to new sepsis patients,” said CEO, John Sperzel.
More on T2 Biosystems
- T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript
- T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript
- T2 Biosystems reports 35% rise in Q3 revenue
- Financial information for T2 Biosystems
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。